Select Page

The Infinium Global Research analyzes the Global Allergy Immunotherapy Market over the period of 2019 to 2025. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in global allergy immunotherapy market. It will help a lot of decision makers to develop strategies and find new opportunities in the global markets of allergy immunotherapy. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the allergy immunotherapy market during the period. The global allergy immunotherapy market is projected to grow at a CAGR of 10.5% over the forecast period of 2019-2025.

“We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.”  The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report:

AIT (Allergy Immunotherapy), is referred to as desensitization, it is the only treatment therapy that targets the cause of allergy.  According to the WAO (World Allergy Organization), around 10%-40% of the total population of the world in 2013 is suffering from various allergy. AIT is a treatment option for asthma and environmental allergies. It is the ultimate goal to influence the immune system and its natural regulation through complex mechanisms.

Allergy Immunotherapy Market: Competitive Analysis

The key players in the allergy immunotherapy market are Aimmune Therapeutics, Biomay, Stallergenes Greer, Abello, Allergy Therapeutics, Merck, Circassia, HAL Allergy, Anergis, DBV Technologies, and many others.

Allergy Immunotherapy Market is Driven by the Development of Novel Products and the Growing Number of Allergic Patients

The allergy immunotherapy market is driven by the development of novel products and the growing number of allergic patients. Moreover, rising consciousness of patients concern to the allergy treatment is also expected to drive the allergy immunotherapy market. However, the allergy tablets are able to heal only a particular type of allergen and remain inefficient to avert the progress of asthma and new allergies are anticipated to restrict the growth of allergy immunotherapy market. Nonetheless, increasing awareness among Patients for allergies is estimated to create a new opportunity for the global allergy immunotherapy market.

Request a Discount on Standard Prices of this Premium Report @

Allergy Immunotherapy Market: Segmentation

The report on the global allergy immunotherapy market covers segments such as type, allergy type, and distribution channel. The type segment is further segmented into the SLIT and SCIT. On the basis of allergy type, the allergy immunotherapy market is segmented into asthma, venom allergy, allergic rhinitis, food allergy, and others. On the basis of the distribution channel, the allergy immunotherapy market is bifurcated into the retail pharmacy and drug stores, hospital pharmacy, and online pharmacy.

North America Accounted for the Second-Largest Market Share for Global Allergy Immunotherapy Market

On the basis of region, the global allergy immunotherapy market is bifurcated into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America accounted for the second-largest market share for global allergy immunotherapy market in 2018. Europe has held the largest revenue share of the global allergy immunotherapy market in 2018 and it is expected to be the dominating region in coming years. Owing to rising in funding for research and development, high awareness, and grants, complimentary medical reimbursement policies. Europe is a highly influensive market for allergy immunotherapy and is estimated to grow at a significant growth rate within the projected years. Promising products of the clinical pipeline, and increasing allergic population.

Browse Detailed TOC and Description of this Exclusive Report@

Reasons to Buy this Report:

  • Comprehensive analysis of global as well as regional markets of the Allergy Immunotherapy.
  • Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2025.
  • Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
  • Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.